BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 24789205)

  • 41. Proton pump inhibitors exacerbate NSAID-induced small intestinal injury by inducing dysbiosis.
    Wallace JL; Syer S; Denou E; de Palma G; Vong L; McKnight W; Jury J; Bolla M; Bercik P; Collins SM; Verdu E; Ongini E
    Gastroenterology; 2011 Oct; 141(4):1314-22, 1322.e1-5. PubMed ID: 21745447
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Transient receptor potential vanilloid 4 activated inflammatory signals by intestinal epithelial cells and colitis in mice.
    D'Aldebert E; Cenac N; Rousset P; Martin L; Rolland C; Chapman K; Selves J; Alric L; Vinel JP; Vergnolle N
    Gastroenterology; 2011 Jan; 140(1):275-85. PubMed ID: 20888819
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Skimmed, sterilized, and concentrated bovine late colostrum promotes both prevention and recovery from intestinal tissue damage in mice.
    Cairangzhuoma ; Yamamoto M; Muranishi H; Inagaki M; Uchida K; Yamashita K; Saito S; Yabe T; Kanamaru Y
    J Dairy Sci; 2013 Mar; 96(3):1347-55. PubMed ID: 23295115
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Silica nanoparticles inhibit the cation channel TRPV4 in airway epithelial cells.
    Sanchez A; Alvarez JL; Demydenko K; Jung C; Alpizar YA; Alvarez-Collazo J; Cokic SM; Valverde MA; Hoet PH; Talavera K
    Part Fibre Toxicol; 2017 Nov; 14(1):43. PubMed ID: 29100528
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Systemic activation of the transient receptor potential vanilloid subtype 4 channel causes endothelial failure and circulatory collapse: Part 2.
    Willette RN; Bao W; Nerurkar S; Yue TL; Doe CP; Stankus G; Turner GH; Ju H; Thomas H; Fishman CE; Sulpizio A; Behm DJ; Hoffman S; Lin Z; Lozinskaya I; Casillas LN; Lin M; Trout RE; Votta BJ; Thorneloe K; Lashinger ES; Figueroa DJ; Marquis R; Xu X
    J Pharmacol Exp Ther; 2008 Aug; 326(2):443-52. PubMed ID: 18499744
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Diazoxide attenuates indomethacin-induced small intestinal damage in the rat.
    Menozzi A; Pozzoli C; Poli E; Passeri B; Gianelli P; Bertini S
    Eur J Pharmacol; 2011 Jan; 650(1):378-83. PubMed ID: 20950601
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Curcumin reduces indomethacin-induced damage in the rat small intestine.
    Sivalingam N; Hanumantharaya R; Faith M; Basivireddy J; Balasubramanian KA; Jacob M
    J Appl Toxicol; 2007; 27(6):551-60. PubMed ID: 17351913
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Rapamycin and Starvation Mitigate Indomethacin-Induced Intestinal Damage through Preservation of Lysosomal Vacuolar ATPase Integrity.
    Shirakawa M; Yokoe S; Nakagawa T; Moriwaki K; Takeuchi T; Asahi M
    J Pharmacol Exp Ther; 2024 Jun; 390(1):108-115. PubMed ID: 38834354
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A transient receptor potential vanilloid 4 contributes to mechanical allodynia following chronic compression of dorsal root ganglion in rats.
    Zhang Y; Wang YH; Ge HY; Arendt-Nielsen L; Wang R; Yue SW
    Neurosci Lett; 2008 Feb; 432(3):222-7. PubMed ID: 18206306
    [TBL] [Abstract][Full Text] [Related]  

  • 50. TRPV4 partially participates in proliferation of human brain capillary endothelial cells.
    Hatano N; Suzuki H; Itoh Y; Muraki K
    Life Sci; 2013 Mar; 92(4-5):317-24. PubMed ID: 23333822
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Differential expression of TRPM2 and TRPV4 channels and their potential role in oxidative stress-induced cell death in organotypic hippocampal culture.
    Bai JZ; Lipski J
    Neurotoxicology; 2010 Mar; 31(2):204-14. PubMed ID: 20064552
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intestinal effects of nonselective and selective cyclooxygenase inhibitors in the rat.
    Menozzi A; Pozzoli C; Giovannini E; Solenghi E; Grandi D; Bonardi S; Bertini S; Vasina V; Coruzzi G
    Eur J Pharmacol; 2006 Dec; 552(1-3):143-50. PubMed ID: 17069793
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Activation of transient receptor potential vanilloid type-1 channel prevents adipogenesis and obesity.
    Zhang LL; Yan Liu D; Ma LQ; Luo ZD; Cao TB; Zhong J; Yan ZC; Wang LJ; Zhao ZG; Zhu SJ; Schrader M; Thilo F; Zhu ZM; Tepel M
    Circ Res; 2007 Apr; 100(7):1063-70. PubMed ID: 17347480
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Revaprazan prevented indomethacin-induced intestinal damages by enhancing tight junction related mechanisms.
    Han YM; Park JM; Her S; Kim MS; Park YJ; Hahm KB
    Biochem Pharmacol; 2020 Dec; 182():114290. PubMed ID: 33075311
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Indomethacin-induced generation of reactive oxygen species leads to epithelial cell injury before the formation of intestinal lesions in mice.
    Tomita T; Sadakata H; Tamura M; Matsui H
    J Physiol Pharmacol; 2014 Jun; 65(3):435-40. PubMed ID: 24930516
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lubiprostone prevents nonsteroidal anti-inflammatory drug-induced small intestinal damage by suppressing the expression of inflammatory mediators via EP4 receptors.
    Hayashi S; Kurata N; Yamaguchi A; Amagase K; Takeuchi K
    J Pharmacol Exp Ther; 2014 Jun; 349(3):470-9. PubMed ID: 24713141
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Transient receptor potential vanilloid 4-mediated disruption of the alveolar septal barrier: a novel mechanism of acute lung injury.
    Alvarez DF; King JA; Weber D; Addison E; Liedtke W; Townsley MI
    Circ Res; 2006 Oct; 99(9):988-95. PubMed ID: 17008604
    [TBL] [Abstract][Full Text] [Related]  

  • 58. High vascular pressure-induced lung injury requires P450 epoxygenase-dependent activation of TRPV4.
    Jian MY; King JA; Al-Mehdi AB; Liedtke W; Townsley MI
    Am J Respir Cell Mol Biol; 2008 Apr; 38(4):386-92. PubMed ID: 17962608
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Epoxyeicosatrienoic acids function as selective, endogenous antagonists of native thromboxane receptors: identification of a novel mechanism of vasodilation.
    Behm DJ; Ogbonna A; Wu C; Burns-Kurtis CL; Douglas SA
    J Pharmacol Exp Ther; 2009 Jan; 328(1):231-9. PubMed ID: 18836067
    [TBL] [Abstract][Full Text] [Related]  

  • 60. NSAID-induced enteropathy: are the currently available selective COX-2 inhibitors all the same?
    Fornai M; Antonioli L; Colucci R; Pellegrini C; Giustarini G; Testai L; Martelli A; Matarangasi A; Natale G; Calderone V; Tuccori M; Scarpignato C; Blandizzi C
    J Pharmacol Exp Ther; 2014 Jan; 348(1):86-95. PubMed ID: 24135073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.